• Pharma
  • July 13, 2018
  • 195 views
USD 550 million awarded in lawsuit linking cancer, baby powder

R St Louis (US): Nearly two dozen women who claimed asbestos in Johnson & Johnson talcum powder caused their ovarian cancer were awarded USD 550 million in damages by a…

  • Pharma
  • July 12, 2018
  • 239 views
Lupin, Boehringer Ingelheim to co-market two oral anti-diabetic drugs in India

New Delhi: Drug major Lupin Wednesday said it has expanded its collaboration with Germany’s Boehringer Ingelheim for co-marketing two oral anti-diabetic drugs in India. The two new oral anti-diabetics drugs…

  • Pharma
  • July 12, 2018
  • 234 views
Religare Finvest claims Rs 1,900 crore from 19 companies ‘known to’ Malvinder and Shivinder Singh

NEW DELHI: Religare Finvest, the lending arm of Religare Enterprises, has filed claims totalling Rs 1,900 crore against 19 companies that were linked to its former promoters Malvinder and Shivinder…

  • Pharma
  • July 12, 2018
  • 189 views
Sun Pharma’s subsidiary files patent infringement suit against German drug maker Biofrontera

Sun pharma’s US subsidiary DUSA pharmaceuticals on Wednesday said that the company has filed a law suit against German drug maker Biofrontera for patent infringement, trade secret misappropriation and tortious…

  • Pharma
  • July 11, 2018
  • 179 views
Glenmark expands its oncology franchise in India with launch of Helsinn’s Akynzeo

New Delhi, Jul 10 : Glenmark Pharmaceuticals and Swiss pharma group Helsinn today announced the launch of Akynzeo, a fixed dose combination drug for prevention of chemotherapy-induced nausea and vomiting,…

  • Pharma
  • July 10, 2018
  • 160 views
Sun Pharma signs Akshay Kumar as brand ambassador for Revital H

New Delhi: Sun Pharma signs Akshay Kumar as brand ambassador for Revital H Drug major Sun Pharmaceutical Industries Monday said Sun Pharma Consumer Healthcare has signed Bollywood star Akshay Kumar…

  • Pharma
  • July 10, 2018
  • 194 views
Aurobindo in last lap to buy Mallinckrodt’s US generics business

MUMBAI: Aurobindo Pharma is in final negotiations to acquire Mallinckrodt’s specialty generics business in the US—including its portfolio of opioid-based painkillers—for $850-900 million after talks resumed in May, said multiple…

  • Pharma
  • July 9, 2018
  • 187 views
Firms marketing medicines may soon be liable for drug regulation violations

CHENNAI: Companies marketing medicines in India will soon be liable for violations of drug regulations that could lead to spurious or substandard medicines even if they aren’t manufacturers of these…

  • Pharma
  • July 7, 2018
  • 215 views
TPG to acquire 40% in Sai Life for Rs 900 crore

Mumbai: TPG has pipped rival private equity investors to acquire a stake of slightly over 40% in Sai Life Sciences — a Hyderabad-based provider of drug discovery, development and manufacturing…

  • Pharma
  • July 6, 2018
  • 199 views
Unsealed lawsuit: Opioid firm placed profits over people

NASHVILLE, Tenn. – A newly unsealed lawsuit by Tennessee’s attorney general says the maker of the world’s top-selling painkiller directed its salesforce to target the highest prescribers, many with limited…